Please provide your email address to receive an email when new articles are posted on . Nathan A. Pennell, MD, PhD, medical oncologist at Cleveland Clinic and associate professor of medical oncology ...
Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results